Design Therapeutics Inc

Gesloten

14.3 8.01

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

13.3

Max

14.37

Belangrijke statistieken

By Trading Economics

Inkomsten

-1.6M

-18M

EPS

-0.29

Werknemers

54

EBITDA

534K

-17M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+55.43% upside

Dividenden

By Acuity

Volgende Winsten

5 aug 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

56M

856M

Vorige openingsprijs

6.29

Vorige sluitingsprijs

14.3

Design Therapeutics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

28 jun 2026, 23:51 UTC

Bitcoin dips while Ethereum rises amid investor caution over stock market leverage and upcoming AI earnings reports.

28 jun 2026, 23:51 UTC

Japan's retail sales data reveals consumer spending trends amid rising concerns over stock market leverage and volatility, as investors brace for upcoming U.S. Non-Farm Payrolls report.

28 jun 2026, 23:51 UTC

Bitcoin dips while Ethereum rises amid investor concerns over high leverage and volatility in equity markets, with key U.S. economic data expected to influence market dynamics.

28 jun 2026, 23:51 UTC

Bitcoin dips as Ethereum rises amid concerns over high leverage in stock markets and anticipation of Meta's earnings report, with key economic data releases on July 2 expected to impact Federal Reserve policy.

28 jun 2026, 23:51 UTC

ECB Forum on Central Banking Set for June 29, 2026: Focus on Monetary Policy and Interest Rates Amid Economic Uncertainties.

28 jun 2026, 23:51 UTC

Macro News

Bitcoin is lower as geopolitical tensions rise and South Korean stocks decline. It is currently about 5.32% below its 20-day moving average.

28 jun 2026, 23:41 UTC

Japan's Retail Sales Expected to Rise 3.2% in May, Boosting Investor Confidence Amid Global Market Concerns

28 jun 2026, 23:41 UTC

Avalanche is higher today, continuing its modest gain since Saturday's close. The price has fluctuated within a narrow range during the session.

28 jun 2026, 23:41 UTC

The FTSE 100 Index is lower after market hours, reflecting cautious investor sentiment amid rising concerns over high leverage and increased equity financing costs.

28 jun 2026, 23:32 UTC

Macro News
Correlated Moves

Ethereum is trading lower amid heightened geopolitical tensions and stock market volatility. Earlier in the session, it rebounded from a session high.

28 jun 2026, 23:22 UTC

Market Awaits BoE Governor Bailey's Speech on Interest Rates Amid AI-Driven Financial Stability Concerns.

28 jun 2026, 23:22 UTC

Market Awaits U.S. Average Hourly Earnings Data Amid Wage Legislation Debates and AI Sector Concerns Impacting Federal Reserve Policy.

28 jun 2026, 23:22 UTC

U.S. Labor Force Participation Rate Report Set for July 2, Amid Employee Dissatisfaction and Minimum Wage Legislation Debates

28 jun 2026, 23:22 UTC

Investors Brace for Insights on Interest Rates as BoC Governor Macklem's Speech Approaches Amid Economic Challenges in Canada

28 jun 2026, 23:22 UTC

U.S. Unemployment Rate Expected to Hold Steady at 4.3% Ahead of July 2 Release Amid Employee Dissatisfaction and Potential Minimum Wage Legislation

28 jun 2026, 23:22 UTC

U.S. Non Farm Payrolls Report on July 2 Forecasts 114K Job Additions Amid Cautious Market Sentiment and Legislative Changes Impacting Labor Dynamics.

28 jun 2026, 23:22 UTC

Market Awaits June 2026 Average Hourly Earnings Data Amidst Wage Growth Concerns and Legislative Push for Minimum Wage Increase.

28 jun 2026, 23:12 UTC

Mexico's Consumer Confidence Index set for July 3, 2026 release amid declining sentiment and cautious market expectations.

28 jun 2026, 23:11 UTC

GBP/CHF remains roughly flat during after-market hours, trading within a routine range since Friday's close amid concerns over high leverage in the stock market.

28 jun 2026, 23:11 UTC

SGD/CHF is trading roughly flat in after-market hours, remaining near the upper end of its one-month range amid broader market volatility concerns.

28 jun 2026, 23:11 UTC

Correlated Moves

USD/SEK remains roughly flat in after-market hours amid concerns about high leverage in the stock market and its impact on volatility.

28 jun 2026, 23:11 UTC

Correlated Moves

CHF/HKD trading remains roughly flat during after-market hours amid concerns over high stock market leverage and increased volatility in equity financing costs.

28 jun 2026, 23:01 UTC

Gold and silver prices are trading higher during the ongoing session, remaining above their 20-day moving average and near the upper end of their one-month range.

28 jun 2026, 23:01 UTC

Correlated Moves

Silver/CHF is lower today, following a decline from earlier highs. The asset trades below its 20-day moving average amid shifting market sentiment and increased volatility.

28 jun 2026, 23:01 UTC

Correlated Moves

Silver/GBP is lower today, reflecting declines in correlated assets like gold. Prices have fluctuated notably, currently near the lower end of its one-month range.

28 jun 2026, 23:01 UTC

Macro News

US 10Y Treasury Bond Index advances amid escalating Middle East tensions and lower oil prices, reflecting cautious investor sentiment near the upper trading range.

28 jun 2026, 23:01 UTC

The US 5Y Treasury Bond Index is trading higher, reflecting increased activity. It remains near the upper end of its one-month trading range.

28 jun 2026, 23:01 UTC

Macro News

Tensions between the U.S. and Iran have reportedly eased, potentially influencing global oil markets. The US 2Y Treasury Bond Index is trading roughly flat.

28 jun 2026, 23:01 UTC

Correlated Moves

Silver/SGD is trading lower, reflecting a challenging market environment and notable volatility. The asset remains significantly below its 20-day moving average.

28 jun 2026, 23:01 UTC

Correlated Moves

Silver/JPY is lower today, reflecting notable volatility and trading near the lower end of its one-month range. The asset is approximately 9.98% below its 20-day moving average.

Peer Vergelijking

Prijswijziging

Design Therapeutics Inc Prognose

Koersdoel

By TipRanks

55.43% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 20.75 USD  55.43%

Hoogste 22 USD

Laagste 20 USD

Gebaseerd op 5 Wall Street-analisten die 12-maands prijsdoelen bieden voor Design Therapeutics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

5 ratings

5

Buy

0

Hold

0

Sell

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Design Therapeutics Inc

Design Therapeutics, Inc. a biopharmaceutical company, researches, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States. The company utilizes its GeneTAC platform to design and develop therapeutic candidates for inherited diseases caused by nucleotide repeat expansion. Its lead product candidates for potentially disease-modifying treatment comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function that brings to neurological, cardiac, and metabolic dysfunction; Myotonic Dystrophy Type-1, a dominantly-inherited, monogenic progressive neuromuscular disease affecting skeletal muscle, heart, brain, and other organs; Fuchs Endothelial Corneal Dystrophy, a genetic eye disease characterized by bilateral degeneration of corneal endothelial cells and progressive loss of vision; and Huntington's Disease, a dominantly inherited, monogenic neurodegenerative disease characterized by movement, cognitive, and psychiatric disorders. Design Therapeutics, Inc. was incorporated in 2017 and is headquartered in Carlsbad, California.
help-icon Live chat